OTC Markets EXMKT - Delayed Quote USD
Item 9 Labs Corp. (INLB)
At close: October 21 at 4:00 PM EDT
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2022) | Next Qtr. (Mar 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -0.04 | -0.04 | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2022) | Next Qtr. (Mar 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 4.5M | 5.5M | 23.5M | 30M |
| Low Estimate | 4.5M | 5.5M | 23.5M | 30M |
| High Estimate | 4.5M | 5.5M | 23.5M | 30M |
| Year Ago Sales | 6.19M | 6.64M | 21.76M | 23.5M |
| Sales Growth (year/est) | -27.30% | -17.10% | 8.00% | 27.70% |
Earnings History
| CURRENCY IN USD | 12/31/2021 | 3/31/2022 | 6/30/2022 | 9/30/2022 |
|---|---|---|---|---|
| EPS Est. | -0.04 | -0.03 | -0.03 | -0.04 |
| EPS Actual | -0.04 | -0.04 | -0.06 | -0.2 |
| Difference | 0 | -0.01 | -0.03 | -0.16 |
| Surprise % | 0.00% | -33.30% | -100.00% | -400.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2022) | Next Qtr. (Mar 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | -0.05 | -0.04 | -0.13 | -0.08 |
| 30 Days Ago | -0.05 | -0.04 | -0.13 | -0.08 |
| 60 Days Ago | -0.05 | -0.04 | -0.13 | -0.08 |
| 90 Days Ago | -0.05 | -0.04 | -0.13 | -0.08 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2022) | Next Qtr. (Mar 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | INLB | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 3.60% |
| Next Qtr. | -- | -- | -- | 7.90% |
| Current Year | -- | -- | -- | 2.50% |
| Next Year | -- | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 11.87% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Initiated | Noble Capital Markets: Outperform | 7/22/2021 |
Related Tickers
VDQSF Gnomestar Craft Inc.
0.0012
0.00%
LRSNF Global Health Clinics Ltd.
0.0011
0.00%
BIOIF Biome Grow Inc.
0.0037
0.00%
AGYTF Allergy Therapeutics plc
0.0600
0.00%
NXGB NxGen Brands Inc.
0.0002
0.00%
NXEN Nexien BioPharma, Inc.
0.0480
+150.00%
GGBXF Green Growth Brands Inc.
0.0000
0.00%
GBHPF Global Hemp Group Inc.
0.0150
0.00%
TMSH TransGlobal Assets Inc.
0.0003
+25.00%
CVSI CV Sciences, Inc.
0.0500
+3.09%